- Home
- ICMB vs CLGN Comparison
ICMB vs CLGN Comparison
Compare ICMB & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICMB
- CLGN
- Stock Information
- Founded
- ICMB 2012
- CLGN 2004
- Country
- ICMB United States
- CLGN Israel
- Employees
- ICMB N/A
- CLGN N/A
- Industry
- ICMB Finance: Consumer Services
- CLGN Industrial Specialties
- Sector
- ICMB Finance
- CLGN Health Care
- Exchange
- ICMB Nasdaq
- CLGN Nasdaq
- Market Cap
- ICMB 41.1M
- CLGN 37.4M
- IPO Year
- ICMB N/A
- CLGN N/A
- Fundamental
- Price
- ICMB $2.78
- CLGN $1.82
- Analyst Decision
- ICMB
- CLGN Strong Buy
- Analyst Count
- ICMB 0
- CLGN 2
- Target Price
- ICMB N/A
- CLGN $12.50
- AVG Volume (30 Days)
- ICMB 54.5K
- CLGN 12.5K
- Earning Date
- ICMB 05-20-2025
- CLGN 05-28-2025
- Dividend Yield
- ICMB 17.14%
- CLGN N/A
- EPS Growth
- ICMB N/A
- CLGN N/A
- EPS
- ICMB 0.45
- CLGN N/A
- Revenue
- ICMB $23,360,165.00
- CLGN $515,000.00
- Revenue This Year
- ICMB N/A
- CLGN $2,177.67
- Revenue Next Year
- ICMB N/A
- CLGN $56.52
- P/E Ratio
- ICMB $6.20
- CLGN N/A
- Revenue Growth
- ICMB N/A
- CLGN N/A
- 52 Week Low
- ICMB $2.46
- CLGN $1.82
- 52 Week High
- ICMB $3.67
- CLGN $6.75
- Technical
- Relative Strength Index (RSI)
- ICMB 42.05
- CLGN 23.18
- Support Level
- ICMB $2.75
- CLGN $2.00
- Resistance Level
- ICMB $2.87
- CLGN $2.40
- Average True Range (ATR)
- ICMB 0.10
- CLGN 0.21
- MACD
- ICMB -0.00
- CLGN -0.01
- Stochastic Oscillator
- ICMB 16.67
- CLGN 3.59
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.